Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

GHRP-2

Pralmorelin, Growth Hormone Releasing Peptide-2, KP-102

Quick Stats
Studies 230
Trials 1
Score 2
2007 pubmed

Melatonin stimulates the release of growth hormone and prolactin by a possible induction of the expression of frog growth hormone-releasing peptide and its related peptide-2 in the amphibian hypothalamus.

Chowdhury. Vishwajit S VS; Yamamoto. Kazutoshi K; Saeki. Izumi I; Hasunuma. Itaru I; Shimura. Taichi T; Tsutsui. Kazuyoshi K

Key Findings

  • Melatonin directly raises the expression of frog GH‑releasing peptide (fGRP) and its related peptide‑2 in the hypothalamus.
  • Higher melatonin levels (e.g., short‑day photoperiods) lead to increased circulating growth hormone (GH) and prolactin (PRL) in bullfrogs.
  • Removing melatonin sources (eye enucleation + pinealectomy) lowers fGRP expression and GH/PRL levels, which can be rescued by melatonin administration.

Practical Outcomes

  • The study hints that melatonin might influence GH release via hypothalamic pathways, but it’s based on frog biology, not humans. For biohackers, it suggests melatonin could have endocrine effects beyond sleep, yet no human dosing or protocol can be derived. More mammalian research is needed before applying this to longevity or performance regimens.

Summary

In bullfrogs, melatonin boosts the production of a brain peptide that makes the pituitary release growth hormone and prolactin. Removing the eyes and pineal gland (the melatonin source) cuts these hormones, while giving melatonin brings them back up. The effect depends on day length, with more melatonin at night increasing the peptide.

Abstract

We recently identified a novel hypothalamic neuropeptide stimulating GH release in bullfrogs and termed it frog GH-releasing peptide (fGRP). The fGRP precursor encodes fGRP and its related peptides (fGRP-RP-1, -RP-2, and -RP-3), and fGRP-RP-2 also stimulates GH and prolactin (PRL) release. Cell bodies and terminals containing these neuropeptides are localized in the suprachiasmatic nucleus (SCN) and median eminence, respectively. To understand the physiological role of fGRP and fGRP-RP-2, we investigated the mechanisms that regulate the expression of these neuropeptides. This study shows that melatonin induces the expression of fGRP and fGRP-RPs in bullfrogs. Orbital enucleation combined with pinealectomy (Ex plus Px) decreased the expression of fGRP precursor mRNA and content of mature fGRP and fGRP-RPs in the diencephalon including the SCN and median eminence. Conversely, melatonin administration to Ex plus Px bullfrogs increased dose-dependently their expressions. The expression of fGRP precursor mRNA was photoperiodically controlled and increased under short-day photoperiods, when the nocturnal duration of melatonin secretion increases. To clarify the mode of melatonin action on the induction of fGRP and fGRP-RPs, we further demonstrated the expression of Mel(1b), a melatonin receptor subtype, in SCN neurons expressing fGRP precursor mRNA. Finally, we investigated circulating GH and PRL levels after melatonin manipulation because fGRP and fGRP-RP-2 stimulate the release of GH and GH/PRL, respectively. Ex plus Px decreased plasma GH and PRL concentrations, whereas melatonin administration increased these hormone levels. These results suggest that melatonin induces the expression of fGRP and fGRP-RP-2, thus stimulating the release of GH and PRL in bullfrogs.

Study Information

Provider

pubmed

Year

2007

Date

2007-12-06T00:00:00.000Z

DOI

10.1210/en.2007-1427